FDA to lift warnings on menopause hormone therapy, potentially boosting access

by

The FDA is asking drug manufacturers to remove black box warnings on hormone replacement therapy for menopause, which could make it easier for women to access the treatment.

View original article
Contributor: Akilah Johnson, Rachel Roubein